(Q28219363)

English

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

scientific article (publication date: 11 August 2007)

In more languages

Statements

scholarly article

0 references

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial (English)

0 references

atrial fibrillation

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

object named as

Gregory Y H Lip

0 references

1

object named as

Jonathan Mant

0 references

1 reference

ORCID Public Data File 2021

Andrea K Roalfe

4

object named as

Andrea Roalfe

0 references

Cody-Ellen P Murray

7

object named as

Ellen Murray

0 references

3

object named as

Kate Fletcher

0 references

author name string

F D Richard Hobbs

2

0 references

David Fitzmaurice

5

0 references

language of work or name

0 references

publication date

11 August 2007

0 references

0 references

370

0 references

493-503

0 references

9586

0 references

A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Controversies surrounding long-term anticoagulation of very elderly patients in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiplatelet versus anticoagulant therapies in advanced age: an unfinished task

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The increasing incidence of anticoagulant-associated intracerebral hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study, Etc.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines on oral anticoagulation: third edition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Applicability to primary care of national clinical guidelines on blood pressure lowering for people with stroke: cross sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961233-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(07)61233-1

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

release_y24bnxgbinhz3jyjrsxf5khopi

1 reference

https://api.fatcat.wiki/v0/release/y24bnxgbinhz3jyjrsxf5khopi

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28219363&oldid=1843222955"